title: Evaluation and Detection of Dysplasia in IBD: the Role of Chromoendoscopy and Enhanced Imaging Techniques.
abstract: Patients with ulcerative colitis (UC) and Crohn's disease (CD) colitis are at significantly higher risk for the development of colitis-associated colorectal cancer (CAC), a risk associated with increased duration and extent of disease [1]. CAC in patients with ulcerative colitis and Crohn's colitis arises from dysplastic tissue in the background of mucosal inflammatory changes. Regular surveillance by colonoscopy is a recommended cancer prevention strategy endorsed by the US and European GI societies [2-4]. Until recently, random sampling of the mucosa throughout the colon has been the mainstay of this conventional surveillance. This requires multiple biopsies to be taken and processed, a practice which is time consuming, expensive, and has a low diagnostic yield. The growth pattern of dysplastic tissue is often multifocal and diffuse, and thus, its detection may not be optimal with the use of traditional white light colonoscopy. According to recent studies, most dysplastic lesions appear to be visible to careful endoscopic inspection [5-7]. Thus, the approach focusing on targeted biopsies of any mucosal abnormalities instead of only random biopsies has been advocated [8]. In addition, the detection and further delineation of any mucosal abnormalities are thought to be improved by the application of dyes that highlight more subtle abnormalities known as chromoendoscopy (CE) as well as a new generation endoscopic system with high-definition white light endoscopy (HDWL). The application of CE in patients with long-term UC was deemed to be beneficial based upon the results of previous clinical trials comparing CE with standard definition white light endoscopy (SDWL) [9•, 10•]. However, there are limited data available comparing CE with the currently broadly used high-definition colonoscopies (HDWL) [11•, 12•, 13•]. High-definition (HD) endoscopy uses a high-definition monitor and a high-resolution CCD (charge-coupled device) providing images of substantially higher resolution than standard video endoscopy. Thus, HDWL colonoscopy may be an alternative to CE in IBD surveillance without the need for the extra time and required experience with CE. Further longitudinal studies are necessary to determine the ultimate advantage of chromoendoscopy or lack of the advantages of chromoendoscopy over that of high-definition colonoscopy in detection of dysplasia. Once lesions are identified by HDWL and CE, they can be further evaluated with evolving technologies to perform in vivo microscopy. Small-field technologies such as confocal endomicroscopy (CLE) permit in vivo microscopic assessment of the colonic mucosa. This evolving technology can be utilized in combination with HDWL and CE in selected cases to further define the lesions and assess their histology, and thus, facilitate real-time in vivo diagnosis and decisions regarding resection of lesions. Further studies to determine the applicability of these newer enhanced technologies in evaluation of dysplasia in routine clinical practice are needed.
authors.affiliation: Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Anna M
authors.initials: AM
authors.lastname: Buchner
authors.affiliation: Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, USA. Gary.lichtenstein@uphs.upenn.edu.|University of Pennsylvania School of Medicine, Perelman Center, 7th Floor South, Room 753, Philadelphia, PA, USA. Gary.lichtenstein@uphs.upenn.edu.|Division of Gastroenterology, Department of Medicine, 3400 Convention Avenue, Philadelphia, PA, 19104, USA. Gary.lichtenstein@uphs.upenn.edu.
authors.forename: Gary R
authors.initials: GR
authors.lastname: Lichtenstein
keywords: Dysplasia; Image Enhanced techniques; Inflammatory bowel disease; Surveillance, chromoendoscopy
references.citation: Clin Gastroenterol Hepatol. 2015 Oct;13(10):1776-1781.e1
references.pmid: 25952309
references.citation: Gut. 2001 Apr;48(4):526-35
references.pmid: 11247898
references.citation: Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524
references.pmid: 20068560
references.citation: Gastroenterology. 2007 Mar;132(3):874-82
references.pmid: 17383417
references.citation: Am J Gastroenterol. 2014 May;109(5):715-22
references.pmid: 21427710
references.citation: Gastrointest Endosc. 2011 Oct;74(4):840-8
references.pmid: 21802681
references.citation: Scand J Gastroenterol. 2008;43(6):698-703
references.pmid: 18569987
references.citation: Gastrointest Endosc. 2016 May;83(5):966-71
references.pmid: 26358329
references.citation: Gastroenterology. 2010 Feb;138(2):746-74, 774.e1-4; quiz e12-3
references.pmid: 20141809
references.citation: Gastroenterology. 2013 Jun;144(7):1349-52, 1352.e1-6
references.pmid: 23583483
references.citation: Endoscopy. 2011 Apr;43(4):374
references.pmid: 21455876
references.citation: Gastroenterology. 1992 Nov;103(5):1611-20
references.pmid: 1426881
references.citation: Gut. 2010 May;59(5):666-89
references.pmid: 20427401
references.citation: Gastroenterology. 2015 Mar;148(3):462-7
references.pmid: 25702851
references.citation: Clin Gastroenterol Hepatol. 2015 Oct;13(10):1782-4
references.pmid: 26122766
references.citation: Gastrointest Endosc. 2007 Jun;65(7):998-1004
references.pmid: 17451704
references.citation: Inflamm Bowel Dis. 2013 Feb;19(2):350-5
references.pmid: 22552948
references.citation: Am J Gastroenterol. 2012 Jun;107(6):885-90
references.pmid: 22613903
references.citation: Gastroenterology. 2015 Mar;148(3):639-651.e28
references.pmid: 25702852
references.citation: Colorectal Dis. 2013 Jan;15(1):e1-12
references.pmid: 23006609
references.citation: Gastrointest Endosc. 2004 Sep;60(3):334-9
references.pmid: 15332019
references.citation: Gastrointest Endosc. 2015 May;81(5):1101-21.e1-13
references.pmid: 25800660
references.citation: Inflamm Bowel Dis. 2013 Aug;19(9):1913-20
references.pmid: 23811635
references.citation: Am J Gastroenterol. 2015 Jul;110(7):1014-21
references.pmid: 25823770
references.citation: Endoscopy. 2011 Feb;43(2):108-15
references.pmid: 21165822
references.citation: Endoscopy. 2011 Feb;43(2):116-22
references.pmid: 21165821
references.citation: Gut. 2008 Feb;57(2):196-204
references.pmid: 18192453
references.citation: Gastrointest Endosc. 2015 Mar;81(3):489-501.e26
references.pmid: 25708752
references.citation: Inflamm Bowel Dis. 2005 Mar;11(3):314-21
references.pmid: 15735438
references.citation: Aliment Pharmacol Ther. 2011 Feb;33(3):304-12
references.pmid: 21128987
references.citation: Endoscopy. 2007 Mar;39(3):216-21
references.pmid: 17385106
references.citation: JAMA. 2008 Mar 5;299(9):1027-35
references.pmid: 18319413